Unither 天美传媒apps, the world鈥檚 leading manufacturer of sterile unit-dose products, recently acquired the Novartis plant in S茫o Paulo, Brazil, as a new step in its industrial expansion in Brazil.
“This acquisition enables us to benefit from sterile operations in Latin America and to enlarge our offer to multidose ophthalmic containers. We are pleased to welcome the 180 people joining Unither 天美传媒apps and bring new possibilities to our customers,” explains Eric Goupil, President of Unither 天美传媒apps.
Unither 天美传媒apps has a major interest in the fast-growing ophthalmology market. Thus, ongoing investments are being made, including the acquisition of this new plant in Latin America, which allows the company to manufacture ophthalmic healthcare products across four continents (Europe, Asia, North America and South America).